macrogol macrogol macrogol, also known as polyethylene glycol (peg), is used as a medication to treat constipation in children and adults. it is also used to empty the bowels before a colonoscopy. it is taken by mouth. benefits usually occur within three days. generally it is only recommended for up to two weeks. it is also used as an excipient. macrogolclinical datatrade namesmiralax, clearlax, golytely, othersother namespolyethylene glycol (peg), peg 3350, peg 4000, peg 6000ahfs/drugs.comprofessional drug factsmedlineplusa603032license data us dailymed: polyethylene_glycol pregnancycategory au: b1 routes ofadministrationby mouthdrug classosmotic laxativeatc codea06ad15 (who) a06ad65 (who)legal statuslegal status uk: p (pharmacy medicines) / pom us: ℞-only / otc rx-only / otc pharmacokinetic databioavailabilitynoneexcretionfaeces (100%)identifiers iupac name poly(oxyethylene) cas number25322-68-3 ydrugbankdb09287 ychemspidernoneunii3wjq0sdw1akeggd11174d03370chemblchembl1201478 nchemical and physical dataformulah–(och2ch2)n–ohmolar massvaries ny (what is this?) (verify) side effects may include increased bowel gas, abdominal pain, and nausea. rare but serious side effects may include an abnormal heartbeat, seizures, and kidney problems. use appears to be safe during pregnancy. it is classified as an osmotic laxative. it works by increasing the amount of water in the stool. macrogol came into use as a bowel prep in 1980 and was approved for medical use in the united states in 1999. it is available as a generic medication and over the counter. in 2020, it was the 226th most commonly prescribed medication in the united states, with more than 2 million prescriptions. typically it is formulated together with electrolytes. medical uses a polyethylene glycol (peg) and electrolytes solution used as a laxative used to cleanse the colon before colonoscopy, lower gastrointestinal series, or colon surgery. constipation macrogol 4000, pharmaceutical quality macrogol 3350, often in combination with electrolytes, is used for short-term relief of constipation as well as for long-term use in constipation of various causes, including in multiple sclerosis and parkinson's disease patients (an often-overlooked non-motor symptom) as well as constipation caused by pharmaceutical drugs such as opioids and anticholinergics. whole bowel irrigation with macrogol is part of the bowel preparation before surgery or colonoscopy. limited data also support its use for the treatment of fecal impaction. in those with chronic constipation it works better than lactulose. a 2007 comparison showed that people with constipation had a better response to macrogol than to tegaserod. popular types include: macrogol 3350, macrogol 4000, and macrogol 6000. the number represents the average molecular mass. combining different molecular masses provides some control over the consistency. excipient macrogol is used as an excipient in pharmaceutical products. lower-molecular-weight variants are used as solvents in oral liquids and soft capsules, whereas solid variants are used as ointment bases, tablet binders, film coatings, and lubricants. for example, peg-2000 is one of the excipients in the moderna covid-19 vaccine. pegylation macrogols are also attached to biopharmaceutical drugs to slow down their degradation in the human body and increase their duration of action, as well as to reduce immunogenicity. this process is called pegylation. contraindications contraindications for macrogol taken orally as a laxative are intestinal perforation, bowel obstruction, ileus, inflammatory bowel diseases, and toxic megacolon. the doses of macrogol as an excipient are too low to have relevant contraindications. allergy to macrogol is rare, and usually appears as an allergy to an increasing number of seemingly unrelated products, including cosmetics, drugs that use it as an excipient, and peri-procedural substances such as ultrasound gel. adverse effects oral macrogol is generally well tolerated. possible side effects include headache, bloating, nausea, allergies, and electrolyte imbalance, mainly hypokalaemia (low blood potassium levels) and hyperkalaemia (high blood potassium levels). hyperkalaemia is not an effect of macrogol itself but of potassium salts which are usually part of macrogol formulations. with excessive use, it can cause diarrhea. interactions the interaction potential is low. absorption of other pharmaceutical drugs can be reduced because oral macrogol accelerates intestinal passage, but this is seldom clinically relevant. for antiepileptic drugs, such a mechanism has been described in rare cases. pharmacology mechanism of action as a laxative macrogol is an osmotically acting laxative; that is, an inert substance that passes through the gut without being absorbed into the body. it relieves constipation because it causes water to be retained in the bowel instead of being absorbed into the body. this increases the water content and volume of the stools in the bowel, making them softer and easier to pass, as well as improving gut motility. available forms macrogol is sold as a non-prescription preparation in the form of powder. when sold for gut cleansing (and as a laxative), it is usually in combination with salts such as sodium bicarbonate, sodium chloride and potassium chloride to help mitigate the possibility of electrolyte imbalance and dehydration. brand names include cosmocol, cololyt, glycoprep, laxido, miralax, molaxole, movicol osmolax. these have varying availability in different countries (see below). it is dissolved in water to create a clear and odorless solution which is then drunk. while most consumers find the taste of macrogol itself to be very mild and unobjectionable, the electrolytes contained in formulations for purging and cleansing give the solution an extremely salty and bitter taste. polyethylene glycol-electrolyte solution is a prescription product sold under various brand names in the us, including colyte, gavilyte, golytely, nulytely, moviprep, and trilyte. moviprep is the only one of these preparations sold under the same brand name in the uk. other brand names available in the uk include cosmocol, klean-prep, laxido, molaxole, movicol, plenvu, transisoft, and vistaprep. research pegylation the protein uricase can be pegylated to form pegloticase, which improves its solubility at physiological ph, increases serum half-life and reduces immunogenicity without compromising activity. upper images show the whole tetramer, lower images show one of the lysines that is pegylated. (pdb: 1uox​ peg-uricase model from reference) main article: pegylation when attached to various biopharmaceutical medications (which are proteins), macrogol results in a slowed clearance of the carried protein from the blood. this makes for a longer-acting medicinal effect and reduces toxicity, and it allows for longer dosing intervals. it also reduces the proteins' immunogenicity. examples for pegylated proteins include peginterferon alfa-2a and -2b, which are used to treat hepatitis c, pegfilgrastim, which is used to treat neutropenia, and pegloticase for the treatment of gout. nerves and spinal cords there is evidence demonstrating peg-induced repair of specific nerve cells in animal models: it has been shown that macrogol can improve healing of spinal injuries in dogs. one of the earlier findings is that macrogol can aid in nerve repair in earthworms. the subcutaneous injection of macrogol 2000 in guinea pigs after spinal cord injury leads to rapid recovery through molecular repair of nerve membranes. the effectiveness of this treatment to prevent paraplegia in humans after an accident is not known yet. macrogol is being used in the repair of motor neurons damaged in crush or laceration incidents in vivo and in vitro. when coupled with melatonin, 75% of damaged sciatic nerves were rendered viable. cancer prevention high-molecular-weight macrogol (e.g., 8000 g/mol) has been shown to be a dietary preventive agent against colorectal cancer in animal models. the chemoprevention database shows macrogol is the most effective known agent for the suppression of chemical carcinogenesis in rats. cancer prevention applications in humans, however, have not yet been tested in clinical trials. other macrogol is also used to fuse b-cells with myeloma cells in monoclonal antibody production.